Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Coloplast A/S (GB:0QBO)
LSE:0QBO
Coloplast A/S (0QBO) Share Price & Analysis
14 Followers
0QBO Stock Chart & Stats
Day’s Rangekr0 - kr0
52-Week Rangekr689.60 - kr977.20
Previous Closekr887.07
Volume32.66K
Average Volume (3M)50.63K
Market Cap
kr198.90B
Enterprise Valuekr220.21B
Total Cash (Recent Filing)kr881.00M
Total Debt (Recent Filing)kr22.19B
Price to Earnings (P/E)39.0
Beta0.58
Next Earnings
Aug 20, 2024EPS Estimate
kr6.01Last Dividend Ex-Date
May 13, 2024Dividend Yield2.37%
Share Statistics
EPS (TTM)22.73
Shares Outstanding210,200,000
10 Day Avg. Volume26,429
30 Day Avg. Volume50,632
Standard Deviation0.06
R-Squared0.02
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr837.29Price Target Upside-5.61% Downside
Rating ConsensusHold
Number of Analyst Covering7
Coloplast A/S News
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
23.54% Mutual Funds
5.50% Other Institutional Investors
70.96% Public Companies and
Individual Investors
0QBO FAQ
What was Coloplast A/S’s price range in the past 12 months?
Coloplast A/S lowest share price was kr689.60 and its highest was kr977.20 in the past 12 months.
What is Coloplast A/S’s market cap?
Currently, no data Available
When is Coloplast A/S’s upcoming earnings report date?
Coloplast A/S’s upcoming earnings report date is Aug 20, 2024 which is in 21 days.
How were Coloplast A/S’s earnings last quarter?
Coloplast A/S released its earnings results on May 07, 2024. The company reported kr10.96 earnings per share for the quarter, beating the consensus estimate of kr5.833 by kr5.127.
Is Coloplast A/S overvalued?
According to Wall Street analysts Coloplast A/S’s price is currently Overvalued.
Does Coloplast A/S pay dividends?
Coloplast A/S pays a Annually dividend of kr5 which represents an annual dividend yield of 2.37%. See more information on Coloplast A/S dividends here
What is Coloplast A/S’s EPS estimate?
Coloplast A/S’s EPS estimate is kr6.01.
How many shares outstanding does Coloplast A/S have?
Coloplast A/S has 210,200,000 shares outstanding.
What happened to Coloplast A/S’s price movement after its last earnings report?
Coloplast A/S reported an EPS of kr10.96 in its last earnings report, beating expectations of kr5.833. Following the earnings report the stock price went down -1.828%.
Which hedge fund is a major shareholder of Coloplast A/S?
Currently, no hedge funds are holding shares in GB:0QBO
---
Coloplast A/S Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.86%
12-Months-Change
Fundamentals
Return on Equity
42.74%
Trailing 12-Months
Asset Growth
36.37%
Trailing 12-Months
Company Description
Coloplast A/S
Coloplast A/S is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and wipes. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
---
0QBO Stock 12 Month Forecast
Average Price Target
kr837.29
▼(-5.61% Downside)
Technical Analysis
Best Analysts Covering 0QBO
1 Year
1 Year Success Rate
7/13 ratings generated profit
1 Year Average Return
+4.48%
upgraded a buy rating 9 days ago
Copying Hassan Al-Wakeel's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of +4.48% per trade.
---